52°F
weather icon Mostly Cloudy

US Begins First Human Trial of Coronavirus Vaccine

US Begins First Human Trial
of Coronavirus Vaccine.
The first human trial to evaluate a
candidate vaccine against the new
coronavirus has begun in Seattle.
The vaccine, called mRNA-1273, was developed by US National Institutes of Health (NIH) scientists and collaborators in Cambridge, Massachusetts.
The NIH announced the trial will enroll
“45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks.”.
Pharmaceuticals and research labs around the world have raced to develop a treatment to the new coronavirus for which there is currently no vaccine available.
The development is a step in the right direction, though the vaccine must pass more trial phases to prove its effectiveness and safety.
It could be up to 18 months
before it becomes available to the public

THE LATEST
What is Medicare’s general enrollment period?

Waiting too long to enroll can result in a penalty that remains in effect for the life of a beneficiary’s Medicare coverage.

‘Be a champion of your own life,’ boxing star urges

“The Fire Inside” shares the inspirational story of how Claressa Shields conquered the odds with a pair of boxing gloves and a positive mindset.